New Research Poster Presentation 5.40
Long-Term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder
Friday, October 30, 2015 12:30 PM
Robert L. Findling, MD, MBA, The Johns Hopkins University and Kennedy Krieger Institute, Baltimore, MD
Ronald Landbloom, MD, Merck & Co., Inc., Whitehouse Station, NJ
Mary Mackle, PhD, Merck & Co., Inc., Whitehouse Station, NJ
Xiao Wu, PhD, Forest Research Institute, an affiliate of Actavis, Inc., Jersey City, NJ
Linda Snow-Adami, BA, Merck & Co., Inc., Whitehouse Station, NJ
Carla Hundt, MD, Forest Research Institute, an affiliate of Actavis, Inc., Jersey City, NJ
